Revenue: The sum of all revenue fields included for a company's operating activities.
Aptevo Therapeutics Inc. (APVO) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-24.13M |
|
-- |
|
-- |
|
$24.60M |
|
$-24.60M |
|
$0.47M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.13M |
|
$-24.60M |
|
$-24.25M |
|
0.28M |
|
0.28M |
|
$-87.38 |
|
$-87.38 |
|
| Balance Sheet Financials | |
$10.66M |
|
$0.54M |
|
$4.93M |
|
$15.59M |
|
$6.21M |
|
-- |
|
$4.63M |
|
$10.84M |
|
$4.75M |
|
$4.75M |
|
$4.75M |
|
1.50M |
|
| Cash Flow Statement Financials | |
$-23.79M |
|
-- |
|
$15.60M |
|
$16.90M |
|
$8.71M |
|
$-8.19M |
|
$1.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-507.47% |
|
-507.47% |
|
-154.77% |
|
-507.47% |
|
$3.17 |
|
$-86.13 |
|
$-86.13 |
|